Inventor · disambiguated record
Zhuoliang Chen
Also filed as: CHEN ZHUOLIANG
33 granted patents·19 pending applications·249 citations·filing 1996–2023
97Inventor score
Files withNOVARTIS AG30CHEN ZHUOLIANG8CHEN CHRISTINE HIU-TUNG3CAFERRO THOMAS RAYMOND2PALERMO MARK G2
Top patents by PatentIndex Score
52 records- 0196US7419975B2Organic compoundsNOVARTIS AG·Filed 2005·Granted Sep 2, 2008·80 cites·10 claims
- 0292US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0392US10934285B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted Mar 2, 2021·5 cites·5 claims
- 0492US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0591US8552003B2(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their usesCHAREST MARK G·Filed 2007·Granted Oct 8, 2013·30 cites·4 claims
- 0690US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0790US10093646B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Oct 9, 2018·7 cites·10 claims
- 0890US9815813B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2015·Granted Nov 14, 2017·13 cites·8 claims
- 0990US8546336B2SMAC peptidometics useful as IAP inhibitorsCHEN ZHUOLIANG·Filed 2012·Granted Oct 1, 2013·15 cites·3 claims
- 1088US10301278B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted May 28, 2019·8 cites·7 claims
- 1186US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 1286US7989441B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Aug 2, 2011·8 cites·8 claims
- 1385US8481542B2Pyridazinyl derivatives as smo inhibitorsHE FENG·Filed 2012·Granted Jul 9, 2013·7 cites·4 claims
- 1485US8044209B2Pyrrolydine derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Oct 25, 2011·8 cites·10 claims
- 1584US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 1682US9409871B2Pyridazinyl derivatives as SMO inhibitorsNOVARTIS AG·Filed 2013·Granted Aug 9, 2016·5 cites·2 claims
- 1781US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 1880US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 1979US9181266B22-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Nov 10, 2015·3 cites·13 claims
- 2079US2024199609A1Compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2023·Application pending·0 cites
- 2177US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2275US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 2375US8993523B2Dimeric IAP inhibitorsCHEN ZHUOLIANG·Filed 2011·Granted Mar 31, 2015·2 cites·35 claims
- 2475US2022348553A11-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of shp2NOVARTIS AG·Filed 2022·Application pending·0 cites
- 2574US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 2670US11905283B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Feb 20, 2024·0 cites·8 claims
- 2769US11401259B21-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Aug 2, 2022·0 cites·4 claims
- 2869US8445440B2Dimeric IAP inhibitorsSTRAUB CHRISTOPHER·Filed 2011·Granted May 21, 2013·3 cites·42 claims
- 2966US10308660B2Compounds and compositions for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2016·Granted Jun 4, 2019·1 cites·20 claims
- 3066US8207183B2Inhibitors of IAPPALERMO MARK G·Filed 2011·Granted Jun 26, 2012·1 cites·15 claims
- 3166US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 3265US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 3364US10774065B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2018·Granted Sep 15, 2020·0 cites·3 claims
- 3464US2010041663A1Organic Compounds as Smo InhibitorsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 3560US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3659US2014275083A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCAFERRO THOMAS RAYMOND·Filed 2014·Application pending·0 cites
- 3758US2025339547A1Met bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3857US10112931B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2017·Granted Oct 30, 2018·0 cites·11 claims
- 3957US2023092679A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4057US2023081720A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4156US8048886B2Substituted pyrazine-3-one-derivatives as IAP inhibitorsNOVARTIS AG·Filed 2007·Granted Nov 1, 2011·0 cites·4 claims
- 4254US2014004101A1Smac peptidometics useful as iap inhibitorsCHEN ZHUOLIANG·Filed 2013·Application pending·0 cites
- 4353US2024269304A1Bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 4451US5686471ADihydrobenzofuran and related compounds useful as anti-inflammatory agentsPROCTER & GAMBLE·Filed 1996·Granted Nov 11, 1997·9 cites·19 claims
- 4550US8058272B2Organic compoundsCHEN ZHUOLIANG·Filed 2007·Granted Nov 15, 2011·0 cites·2 claims
- 4650US2023091510A1Antibody drug conjugates having linkers comprising hydrophilic groupsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4750US2011281845A1Organic compoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 4849US8338440B2Inhibitors of IAPPALERMO MARK G·Filed 2012·Granted Dec 25, 2012·0 cites·17 claims
- 4949US2024042051A1Mcl-1 inhibitor antibody-drug conjugates and methods of useROCCHETTI FRANCESCA·Filed 2021·Application pending·0 cites
- 5045US2011319614A1Organic CompoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhuoliang Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →